Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 50

The DOI matches its Crossref record.

Treatment Strategy for “Non-Responders” to Tadalafil and Vardenafil: A Real-Life Study

Hatzimouratidis, Konstantinos, Moysidis, Kyriakos, Bekos, Athanasios, Tsimtsiou, Zoi, Ioannidis, Evangelos, Hatzichristou, Dimitrios·2006·European Urology
DOI 10.1016/j.eururo.2006.02.060
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.eururo.2006.02.060

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 23

  1. Lue, 2004, Summary of the recommendations on sexual dysfunctions in men, J Sex Med, 1, 6, 10.1111/j.1743-6109.2004.10104.x · DOI · Paper page
  2. Hatzimouratidis, 2005, A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?, Drugs, 65, 1621, 10.2165/00003495-200565120-00003 · DOI
  3. Hatzichristou, 2002, Diagnostic steps in the evaluation of patients with erectile dysfunction, J Urol, 168, 615, 10.1016/S0022-5347(05)64690-3 · DOI
  4. Hatzichristou, 2005, Sildenafil failures may be due to inadequate patient instructions and follow-up: a study on 100 non-responders, Eur Urol, 47, 518, 10.1016/j.eururo.2004.12.005 · DOI · Paper page
  5. McCullough, 2002, Achieving treatment optimization with sildenafil citrate (Viagra®) in patients with erectile dysfunction, Urology, 60, 28, 10.1016/S0090-4295(02)01688-6 · DOI
  6. Atiemo, 2003, Salvage of sildenafil failures referred from primary care physicians, J Urol, 170, 2356, 10.1097/01.ju.0000096221.67967.ae · DOI
  7. Hatzichristou, 2004, The efficacy and safety of flexible-dose vardenafil (levitra) in a broad population of European men, Eur Urol, 45, 634, 10.1016/j.eururo.2004.01.014 · DOI
  8. Potempa, 2004, Efficacy of vardenafil in men with erectile dysfunction: a flexible-dose community practice study, Eur Urol, 46, 73, 10.1016/j.eururo.2004.03.011 · DOI
  9. Montorsi, 2004, Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction, Eur Urol, 45, 339, 10.1016/j.eururo.2003.11.010 · DOI
  10. Skoumal, 2004, Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction, Eur Urol, 46, 362, 10.1016/j.eururo.2004.04.026 · DOI
  11. McMahon, 2004, Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil, J Sex Med, 1, 292, 10.1111/j.1743-6109.04042.x · DOI · Paper page
  12. Mirone, 2005, An evaluation of an alternative dosing regimen with tadalafil, 3times/week, for men with erectile dysfunction: SURE study in 14 European countries, Eur Urol, 47, 846, 10.1016/j.eururo.2005.02.019 · DOI
  13. Carson, 2004, The ‘effectiveness’ scale—therapeutic outcome of pharmacologic therapies for ED: an international consensus panel report, Int J Impot Res, 16, 207, 10.1038/sj.ijir.3901227 · DOI
  14. Rutchik, 2001, Practice patterns in the diagnosis and treatment of erectile dysfunction among family practice physicians, Urology, 57, 146, 10.1016/S0090-4295(00)00880-3 · DOI · Paper page
  15. Hatzichristou, 2002, Sildenafil citrate: lessons learned from 3 years of clinical experience, Int J Impot Res, 14, S43, 10.1038/sj.ijir.3900805 · DOI · Paper page
  16. von Keitz, 2004, A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil, Eur Urol, 45, 499, 10.1016/j.eururo.2003.11.030 · DOI · Paper page
  17. Rosano, 2005, Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk, Eur Urol, 47, 214, 10.1016/j.eururo.2004.10.002 · DOI · Paper page
  18. Halcox, 2002, The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia, J Am Coll Cardiol, 40, 1232, 10.1016/S0735-1097(02)02139-3 · DOI · Paper page
  19. Desouza, 2002, Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes, Diabetes Care, 25, 1336, 10.2337/diacare.25.8.1336 · DOI
  20. Katz, 2000, Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure, J Am Coll Cardiol, 36, 845, 10.1016/S0735-1097(00)00790-7 · DOI · Paper page
  21. Kimura, 2003, PDE5 inhibitor sildenafil citrate augments endothelium-dependent vasodilation in smokers, Hypertension, 41, 1106, 10.1161/01.HYP.0000068202.42431.CC · DOI
  22. Hatzichristou, 2005, Sildenafil failures may be due to inadequate patient instructions and follow-up: A Study on 100 Non-Responders, Eur Urol, 47, 518, 10.1016/j.eururo.2004.12.005 · DOI · Paper page
  23. Montorsi, 2006, Can phosphodiesterase type 5 inhibitors cure erectile dysfunction?, Eur Urol, 49, 979, 10.1016/j.eururo.2005.12.055 · DOI

Cited by

Metadata

Authors
Hatzimouratidis, K., Moysidis, K., Bekos, A., Tsimtsiou, Z., Ioannidis, E., & Hatzichristou, D.
Venue
European Urology
Publisher
Elsevier BV
Published
2006-07
Volume
50
Issue
1
Pages
126-133
ISSN
0302-2838
DOI
10.1016/j.eururo.2006.02.060
Cited by
50
References
0
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.